Project Grant HT94252310046
Award Date 1/15/23
Completion Date 1/14/25
Dollars Obligated $312K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
- The Regents of the University of Michigan was awarded a $587,862 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research for the "ULTRASENSITIVE DETECTION OF A 'BINARY' BLOOD BIOMARKER FOR ENDOMETRIAL CANCER". The award period runs from July 15, 2024 to July 14, 2026. The project aims to develop an ultrasensitive detection method for a binary blood biomarker to aid in the early diagnosis of endometrial...
- This $1,555,176 federal Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) will support the University of Michigan's research on therapeutic modulation of the serine/threonine phosphatase PP2A for the treatment of uterine serous cancer (USC) and uterine carcinosarcoma (UCS). The award, which runs from Aug 2024 to Aug 2027, will enable the University to conduct advanced biomedical research aimed at transforming...
- The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $467,742 Project Grant to the Regents of the University of Michigan to optimize a risk stratification model for ovarian cancer. The award will support research activities from September 1, 2024 through August 31, 2026. The University of Michigan, a top public research institution, has extensive experience conducting federal research and development projects for agencies such as the...
- The Defense Health Agency awarded a Project Grant titled "PROGESTIN THERAPY FOR ENDOMETRIAL CANCER" to the University of Utah in the amount of $470,919.00 under the Military Medical Research and Development program (CFDA 12.420). The grant, with a period of performance from August 1, 2023 to July 31, 2027, will fund research to investigate medical solutions for the battlefield, with a focus on transforming healthcare for Service Members and the American public through innovative and...
- The Defense Health Agency awarded a $607,377 Project Grant to the Regents of the University of Michigan to fund a 2-year research project titled "A NEW IDEA FOR ADVANCING AXITINIB-BASED THERAPY IN RECURRENT AND METASTATIC HNSCC." This grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. The University of Michigan, a leading...
- The Department of Defense's Defense Health Agency awarded a $1,100,747 Project Grant on April 1, 2025 to the Regents of the University of Michigan to conduct research on "Protein Engineering of Antibody-Drug Conjugates to Coordinate the Innate and Adaptive Immune Systems for Curative Responses" under the Military Medical Research and Development program (CFDA 12.420). This research aims to develop innovative medical solutions that address critical health challenges relevant to military...
- The Defense Health Agency awarded a $1,178,939.00 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development program (CFDA 12.420) to conduct advanced phenotyping research to improve diagnostic, longitudinal assessment, and treatment strategies for deployment-related respiratory disease. The award period is from September 1, 2023 to August 31, 2026. As a U.S. Government Entity and top public research university, the University of Michigan has...
- This $1,529,953 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of Miami to understand the genomic landscape of endometrial cancer in Black women. The project aims to advance scientific understanding of this disease and its impact on a population that is disproportionately affected. The research will be conducted by the University of Miami's Office of Research Administration -...
- The University of Michigan will receive $1.2 million from the Defense Health Agency under a three-year Project Grant award for research titled "FADD: A Mechanistic Basis and Therapeutic Opportunity for Overcoming CDK4/6 Inhibitor Resistance." The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for...
- This Project Grant award of $546,000.00 from the Defense Health Agency supports research at the Regents of the University of Michigan to develop a novel lectin for targeting T-cell lymphomas. The award is part of the Military Medical Research and Development program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for service members and the public through innovative and impactful research. The 3-year award began on September 1, 2023 and will...